June 30, 2011
Impax Laboratories Inc. said Thursday it had resolved patent litigation brought by Daiichi Sankyo Inc and Genzyme Corp. in Delaware over cholesterol drug Welchol, striking a deal that will allow Impax to launch a generic version in 2015.